OÜ ENDOKRINOLOOGIAKESKUS is a OÜ based in Tartu linn, registry code 10914557, status: active. Main activity: Medical specialists activities. According to EMTA, turnover for Q3 2026 was €53 785 with 3 employees.
Turnover
53 785 €
↓ 17.3%vs Q2 2026
State taxes
—
Labour taxes
—
Employees
3
±0vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Human health activities · EMTAK 86
Turnover · Q3 202653 785 €
above 87% of companies
industry median 9 428 € · companies in the industry: 351
Revenue · 2025320 850 €
above 82% of companies
industry median 20 811 € · companies in the industry: 3 373
Net profit margin · 202553.2 %
above 89% of companies
industry median 8.3 % · companies in the industry: 2 759
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € thousand Q3 2026: 53 785 € · −17.3% vs Q2 2026 · industry median 9 428 € · above 87% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Labour taxes per employee, € Q2 2026: 0 € · industry median 2 159 € · above 2% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
EmployeesQ3 2026: 3 · +0.0% vs Q2 2026State taxes, € Q2 2026: 8 137 € · −73.6% vs Q1 2026
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q3 2026
53 785
—
—
3
Q2 2026
65 073
8 137
—
3
Q1 2026
99 514
30 800
—
3
Q4 2025
82 644
160
—
2
Q3 2025
37 457
—
—
2
Q2 2025
105 588
45 282
—
2
Q1 2025
76 896
—
—
2
Q4 2024
78 257
—
—
2
Q3 2024
60 493
—
—
2
Q2 2024
99 229
47 371
4 434
2
Q1 2024
67 116
—
—
2
Q4 2023
71 641
—
—
2
Q3 2023
52 550
—
—
2
Q2 2023
82 429
32 418
1 377
2
Q1 2023
74 486
—
—
2
Q4 2022
63 827
154
156
2
Q3 2022
44 607
704
715
3
Q2 2022
65 322
14 246
2 049
3
Q1 2022
46 268
664
677
3
Turnover per employee in the quarter
17 928 €
Q3 2026 · calculated from EMTA data
Financials by year
2016 – 2025
Revenue, € thousand 2025: 320 850 € · +1.5% vs 2024 · industry median 20 811 € · above 82% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € thousand 2025: 170 608 € · +5.5% vs 2024 · industry median 1 071 € · above 98% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2025: 53.2 % · +2.0 pp vs the year before · industry median 8.3 % · above 89% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € thousand 2025: 179 834 € · +1.3% vs 2024Equity, € thousand 2025: 179 653 € · +6.3% vs 2024Employees2025: 0 · industry median 2 · above 2% of the industry
Company
Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
320 850
170 608
0
179 834
179 653
0
2024
316 040
161 784
0
177 470
169 045
0
2023
288 559
191 931
0
197 142
196 672
0
2022
242 113
165 194
2 165
175 987
168 183
1
2021
55 507
24 372
1 793
76 625
74 186
1
2020
13 799
-12 541
1 802
50 899
49 814
1
2019
51 024
7 334
9 571
70 587
62 373
1
2018
—
—
—
—
—
1
2017
—
—
—
—
—
1
2016
—
—
—
—
—
2
2015
—
—
—
—
—
3
2014
—
—
—
—
—
3
2013
—
—
—
—
—
3
2012
—
—
—
—
—
3
2011
—
—
—
—
—
3
2010
—
—
—
—
—
3
2009
—
—
—
—
—
3
2008
—
—
—
—
—
4
2007
—
—
—
—
—
5
2006
—
—
—
—
—
5
2005
—
—
—
—
—
5
2004
—
—
—
—
—
3
2003
—
—
—
—
—
0
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.